Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Leishmania | Case report

A trespasser from a foreign land? A case report of primary mucosal leishmaniasis

Authors: Yoram Fleissig, Mary Dan-Gur, Ayelet Michael-Gayego, Alexander Maly, Rami Tabib, Charles L. Jaffe, Maya Korem

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

We report a clinically challenging and unusual case of L. donovani oral mucosal leishmaniasis.

Case presentation

Israeli resident with a former travel to central and North Africa, with no documented or prior cutaneous lesions presented with oral lesions of the maxillary gingiva and the upper lip. A delay in diagnosis and treatment have led to progression of the maxillary gingival lesions towards the hard palatal and the soft palate that could have potentially compromised the upper airway.

Conclusions

This case highlights the importance of early diagnosis of leishmaniasis in patients with oral lesions and the laboratory workup necessary to appropriately characterize and treat the disease.
Literature
1.
go back to reference Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho EM, Ephros M, Jeronimo S, Magill A. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Society of America (IDSA) and the American Society of Tropical Medicine and hygene (ASTMK). Clin Infect Dis. 2016;63:e202-64. https://doi.org/10.1093/cid/ciw670.CrossRefPubMed Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho EM, Ephros M, Jeronimo S, Magill A. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Society of America (IDSA) and the American Society of Tropical Medicine and hygene (ASTMK). Clin Infect Dis. 2016;63:e202-64. https://​doi.​org/​10.​1093/​cid/​ciw670.CrossRefPubMed
5.
go back to reference Ya’ari A, Jaffe CL, Garty BZ. Visceral leishmaniasis in Israel, 1960–2000. Isr Med Assoc J. 2004;6:205–8.PubMed Ya’ari A, Jaffe CL, Garty BZ. Visceral leishmaniasis in Israel, 1960–2000. Isr Med Assoc J. 2004;6:205–8.PubMed
10.
go back to reference Kurizky PS, Marianelli FF, Cesetti MV, Damiani G, Ribeiro Sampaio RN, Tanaka Gonçalves LM, de Sousa CAF, Martins SS, Vernal S, da Mota LMH, Gomes CM. A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases. Rev Inst Med Trop Sao Paulo. 2020;62:e28. https://doi.org/10.1590/s1678-9946202062028.CrossRefPubMedPubMedCentral Kurizky PS, Marianelli FF, Cesetti MV, Damiani G, Ribeiro Sampaio RN, Tanaka Gonçalves LM, de Sousa CAF, Martins SS, Vernal S, da Mota LMH, Gomes CM. A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases. Rev Inst Med Trop Sao Paulo. 2020;62:e28. https://​doi.​org/​10.​1590/​s1678-9946202062028.CrossRefPubMedPubMedCentral
Metadata
Title
A trespasser from a foreign land? A case report of primary mucosal leishmaniasis
Authors
Yoram Fleissig
Mary Dan-Gur
Ayelet Michael-Gayego
Alexander Maly
Rami Tabib
Charles L. Jaffe
Maya Korem
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07169-w

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.